Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3260018rdf:typepubmed:Citationlld:pubmed
pubmed-article:3260018lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3260018lifeskim:mentionsumls-concept:C0007776lld:lifeskim
pubmed-article:3260018lifeskim:mentionsumls-concept:C0021549lld:lifeskim
pubmed-article:3260018lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:3260018pubmed:issue3lld:pubmed
pubmed-article:3260018pubmed:dateCreated1988-7-22lld:pubmed
pubmed-article:3260018pubmed:abstractTextSpecific, saturable and reversible binding of [3H]inositol 1,4,5-triphosphate (IP3) was demonstrated to membranes prepared from autopsied cerebral cortices from 6 subjects who were free from psychiatric or neurological disease. The binding has an affinity of 27 +/- 8 nM (mean +/- S.E.M.); capacity (Bmax) of 1.09 +/- 0.18 pmol/mg protein and is reversible in the presence of an excess of unlabelled IP3. These [3H]IP3 binding sites are likely to be physiologically significant receptors which merit further characterization in the normal and diseased human brain.lld:pubmed
pubmed-article:3260018pubmed:languageenglld:pubmed
pubmed-article:3260018pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3260018pubmed:citationSubsetIMlld:pubmed
pubmed-article:3260018pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3260018pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3260018pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3260018pubmed:statusMEDLINElld:pubmed
pubmed-article:3260018pubmed:monthMaylld:pubmed
pubmed-article:3260018pubmed:issn0304-3940lld:pubmed
pubmed-article:3260018pubmed:authorpubmed-author:KishS JSJlld:pubmed
pubmed-article:3260018pubmed:authorpubmed-author:MAP YPYlld:pubmed
pubmed-article:3260018pubmed:authorpubmed-author:WarshJ JJJlld:pubmed
pubmed-article:3260018pubmed:authorpubmed-author:GansP JPJlld:pubmed
pubmed-article:3260018pubmed:authorpubmed-author:YoungL TLTlld:pubmed
pubmed-article:3260018pubmed:issnTypePrintlld:pubmed
pubmed-article:3260018pubmed:day3lld:pubmed
pubmed-article:3260018pubmed:volume87lld:pubmed
pubmed-article:3260018pubmed:ownerNLMlld:pubmed
pubmed-article:3260018pubmed:authorsCompleteYlld:pubmed
pubmed-article:3260018pubmed:pagination283-7lld:pubmed
pubmed-article:3260018pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3260018pubmed:meshHeadingpubmed-meshheading:3260018-...lld:pubmed
pubmed-article:3260018pubmed:meshHeadingpubmed-meshheading:3260018-...lld:pubmed
pubmed-article:3260018pubmed:meshHeadingpubmed-meshheading:3260018-...lld:pubmed
pubmed-article:3260018pubmed:meshHeadingpubmed-meshheading:3260018-...lld:pubmed
pubmed-article:3260018pubmed:meshHeadingpubmed-meshheading:3260018-...lld:pubmed
pubmed-article:3260018pubmed:meshHeadingpubmed-meshheading:3260018-...lld:pubmed
pubmed-article:3260018pubmed:meshHeadingpubmed-meshheading:3260018-...lld:pubmed
pubmed-article:3260018pubmed:meshHeadingpubmed-meshheading:3260018-...lld:pubmed
pubmed-article:3260018pubmed:meshHeadingpubmed-meshheading:3260018-...lld:pubmed
pubmed-article:3260018pubmed:meshHeadingpubmed-meshheading:3260018-...lld:pubmed
pubmed-article:3260018pubmed:meshHeadingpubmed-meshheading:3260018-...lld:pubmed
pubmed-article:3260018pubmed:meshHeadingpubmed-meshheading:3260018-...lld:pubmed
pubmed-article:3260018pubmed:meshHeadingpubmed-meshheading:3260018-...lld:pubmed
pubmed-article:3260018pubmed:year1988lld:pubmed
pubmed-article:3260018pubmed:articleTitle[3H]inositol 1,4,5-triphosphate binding in human cerebral cortex.lld:pubmed
pubmed-article:3260018pubmed:affiliationDepartment of Psychiatry, University of Toronto, Ont., Canada.lld:pubmed
pubmed-article:3260018pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3260018pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3260018lld:pubmed